MAYZENT vs TERIFLUNOMIDE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Possible drug interaction. MAYZENT and TERIFLUNOMIDE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	MAYZENT	TERIFLUNOMIDE
Rating	70/100	56/100
Pharmacy pays	—	~$16.32 /30
Type	RX	RX
Active ingredient	SIPONIMOD	TERIFLUNOMIDE
Manufacturer	Novartis	Teva
Dosage forms	Tablet	Tablet
Drug class	—	Pyrimidine Synthesis Inhibitor
Boxed warning	None	Boxed warning
Treats	Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis	Relapsing-Remitting Multiple Sclerosis

mayzent teriflunomide

Rating

70/100

56/100

Pharmacy pays

—

~$16.32 /30

Type

Active ingredient

SIPONIMOD

TERIFLUNOMIDE

Manufacturer

Novartis

Teva

Dosage forms

Tablet

Drug class

—

Pyrimidine Synthesis Inhibitor

Boxed warning

None

Boxed warning

Treats

Chronic Progressive Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis

Frequently asked questions

Which is better-rated, Mayzent or Teriflunomide?

By our independent rating, Mayzent scores higher — 3.5 vs 2.8 out of 5 for Teriflunomide. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Mayzent and Teriflunomide?

Mayzent contains Siponimod, while Teriflunomide contains Teriflunomide — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.